Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A P...

por Okubo, Tomomi, Atsukawa, Masanori, Tsubota, Akihito, Ono, Hiroki, Kawano, Tadamichi, Yoshida, Yuji, Arai, Taeang, Hayama, Korenobu, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Iwakiri, Katsuhiko
Publicado 2021

A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C

por Yoshida, Yuji, Atsukawa, Masanori, Kondo, Chisa, Kitamura, Michika, Shioda-Koyano, Kaori, Kawano, Tadamichi, Ono, Hiroki, Hayama, Korenobu, Okubo, Tomomi, Arai, Taeang, Itokawa, Norio, Iwakiri, Katsuhiko
Publicado 2023

How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by...

por Atsukawa, Masanori, Tsubota, Akihito, Tamura, Yuichi, Koyano‐Shioda, Kaori, Kawano, Tadamichi, Okubo, Tomomi, Hayama, Korenobu, Arai, Taeang, Itokawa, Norio, Taniguchi, Yu, Tamura, Yudai, Kondo, Chisa, Iwakiri, Katsuhiko
Publicado 2023

Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Ono, Hirotaka, Kawano, Tadamichi, Yoshida, Yuji, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Nagao, Mototsugu, Iwakiri, Katsuhiko
Publicado 2022

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Kawano, Tadamichi, Koeda, Mai, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Kawamoto, Chiaki, Hatori, Tsutomu, Emoto, Naoya, Iio, Etsuko, Tanaka, Yasuhito, Iwakiri, Katsuhiko
Publicado 2019

Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease

por Kawano, Tadamichi, Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Toyoda, Hidenori, Takaguchi, Koichi, Tani, Joji, Morishita, Asahiro, Hiraoka, Atsushi, Mikami, Shigeru, Ishikawa, Toru, Okubo, Hironao, Watanabe, Tsunamasa, Okubo, Tomomi, Arai, Taeang, Hayama, Korenobu, Itokawa, Norio, Kondo, Chisa, Iwakiri, Katsuhiko
Publicado 2022

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-worl...

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Mikami, Shigeru, Ono, Hiroki, Kawano, Tadamichi, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Nakagawa-Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Emoto, Naoya, Nagao, Mototsugu, Inagaki, Kyoko, Fukuda, Izumi, Sugihara, Hitoshi, Iwakiri, Katsuhiko
Publicado 2021

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Kato, Keizo, Abe, Hiroshi, Ono, Hirotaka, Kawano, Tadamichi, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Nakagawa-Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Emoto, Naoya, Nagao, Mototsugu, Inagaki, Kyoko, Fukuda, Izumi, Sugihara, Hitoshi, Iwakiri, Katsuhiko
Publicado 2021

Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Mikami, Shigeru, Haruki, Uojima, Yoshikata, Keiichiro, Ono, Hiroki, Kawano, Tadamichi, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Nagao, Mototsugu, Inagaki, Kyoko, Fukuda, Izumi, Sugihara, Hitoshi, Iwakiri, Katsuhiko
Publicado 2022